BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 31724901)

  • 1. Pharmacological limitations of phage therapy.
    Nilsson AS
    Ups J Med Sci; 2019 Nov; 124(4):218-227. PubMed ID: 31724901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
    Dąbrowska K; Abedon ST
    Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
    Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
    Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage Therapy: The Pharmacology of Antibacterial Viruses.
    Danis-Wlodarczyk K; Dąbrowska K; Abedon ST
    Curr Issues Mol Biol; 2021; 40():81-164. PubMed ID: 32503951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage therapy for severe bacterial infections: a narrative review.
    Petrovic Fabijan A; Khalid A; Maddocks S; Ho J; Gilbey T; Sandaradura I; Lin RC; Ben Zakour N; Venturini C; Bowring B; Iredell JR
    Med J Aust; 2020 Apr; 212(6):279-285. PubMed ID: 31587298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phage therapy, an alternative to antibiotic therapy?)].
    Reina J; Reina N
    Rev Esp Quimioter; 2018 Apr; 31(2):101-104. PubMed ID: 29451376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application?
    Maciejewska B; Olszak T; Drulis-Kawa Z
    Appl Microbiol Biotechnol; 2018 Mar; 102(6):2563-2581. PubMed ID: 29442169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.
    Cisek AA; Dąbrowska I; Gregorczyk KP; Wyżewski Z
    Curr Microbiol; 2017 Feb; 74(2):277-283. PubMed ID: 27896482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage therapy for respiratory infections.
    Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
    Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
    Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
    J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage therapy efficacy: a review of the last 10 years of preclinical studies.
    Melo LDR; Oliveira H; Pires DP; Dabrowska K; Azeredo J
    Crit Rev Microbiol; 2020 Feb; 46(1):78-99. PubMed ID: 32091280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage therapy: breathing new tactics into lower respiratory tract infection treatments.
    Vaezi A; Healy T; Ebrahimi G; Rezvankhah S; Hashemi Shahraki A; Mirsaeidi M
    Eur Respir Rev; 2024 Apr; 33(172):. PubMed ID: 38925791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards Inhaled Phage Therapy in Western Europe.
    Wienhold SM; Lienau J; Witzenrath M
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30909579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
    Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
    Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria.
    El-Shibiny A; El-Sahhar S
    Can J Microbiol; 2017 Nov; 63(11):865-879. PubMed ID: 28863269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Wake-Up Call: We Need Phage Therapy Now.
    Moelling K; Broecker F; Willy C
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30563034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and Pharmacodynamic Obstacles for Phage Therapy From the Perspective of Clinical Practice.
    Międzybrodzki R; Kasprzak H; Letkiewicz S; Rogóż P; Żaczek M; Thomas J; Górski A
    Clin Infect Dis; 2023 Nov; 77(Suppl 5):S395-S400. PubMed ID: 37932117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steering Phages to Combat Bacterial Pathogens.
    Gurney J; Brown SP; Kaltz O; Hochberg ME
    Trends Microbiol; 2020 Feb; 28(2):85-94. PubMed ID: 31744662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.